➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Merck
Moodys
Colorcon
Baxter

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

Bumetanide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for bumetanide and what is the scope of patent protection?

Bumetanide is the generic ingredient in two branded drugs marketed by Athenex Inc, Hospira, Teva Parenteral, West-ward Pharms Int, Validus Pharms, Amneal Pharms Co, Heritage Pharma, Rising, Sandoz, Upsher Smith Labs, and Zydus Pharms, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for bumetanide. Twenty-three suppliers are listed for this compound.

Drug Prices for bumetanide

See drug prices for bumetanide

Drug Sales Revenue Trends for bumetanide

See drug sales revenues for bumetanide

Recent Clinical Trials for bumetanide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lawson Health Research InstituteN/A
Hospital General de México Dr. Eduardo LiceagaPhase 4
B&A TherapeuticsPhase 2

See all bumetanide clinical trials

Pharmacology for bumetanide
Medical Subject Heading (MeSH) Categories for bumetanide

US Patents and Regulatory Information for bumetanide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs BUMETANIDE bumetanide TABLET;ORAL 209916-002 Jan 23, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Hospira BUMETANIDE bumetanide INJECTABLE;INJECTION 074160-001 Oct 30, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-001 Oct 18, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Teva Parenteral BUMETANIDE bumetanide INJECTABLE;INJECTION 074613-001 Nov 18, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Amneal Pharms Co BUMETANIDE bumetanide TABLET;ORAL 209724-002 Oct 18, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for bumetanide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-001 Feb 28, 1983   Start Trial   Start Trial
Validus Pharms BUMEX bumetanide INJECTABLE;INJECTION 018226-001 Feb 28, 1983   Start Trial   Start Trial
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985   Start Trial   Start Trial
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-002 Feb 28, 1983   Start Trial   Start Trial
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Baxter
McKesson
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.